Heart Test Laboratories, Inc. (NASDAQ:HSCS) Short Interest Down 11.8% in August

Heart Test Laboratories, Inc. (NASDAQ:HSCS) was the target of a significant decrease in short interest during the month of August. As of August 31st, there was short interest totalling 39,700 shares, a decrease of 11.8% from the August 15th total of 45,000 shares. Currently, 5.5% of the company’s shares are sold short. Based on an average trading volume of 57,900 shares, the short-interest ratio is currently 0.7 days.

Heart Test Laboratories Stock Down 2.4 %

Heart Test Laboratories stock traded down $0.07 during mid-day trading on Wednesday, hitting $2.81. 16,061 shares of the stock were exchanged, compared to its average volume of 57,723. The stock has a market capitalization of $1.84 million, a price-to-earnings ratio of -0.06 and a beta of 3.13. Heart Test Laboratories has a 12 month low of $2.36 and a 12 month high of $75.47. The firm’s fifty day simple moving average is $3.47 and its two-hundred day simple moving average is $6.82.

Heart Test Laboratories Company Profile

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.